We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+1.5%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$21.4B
AUM Growth
-$3.07B
Cap. Flow
-$3.45B
Cap. Flow %
-16.12%
Top 10 Hldgs %
34%
Holding
335
New
40
Increased
37
Reduced
44
Closed
34

Top Buys

Rank Stock Value
1
ARMK icon
Aramark
ARMK
+$209M
2
KSU
Kansas City Southern
KSU
+$193M
3
HWM icon
Howmet Aerospace
HWM
+$184M
4
MIC
Macquarie Infrastructure Holdings, LLC
MIC
+$172M
5
TMUS icon
T-Mobile US
TMUS
+$160M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$1.42B
2
MXIM
Maxim Integrated Products
MXIM
+$476M
3
WTW icon
Willis Towers Watson
WTW
+$468M
4
WORK
Slack Technologies, Inc.
WORK
+$462M
5
AON icon
Aon
AON
+$371M

Sector Composition

Rank Sector Weight
1 Healthcare 28.83%
2 Technology 13.3%
3 Industrials 11.55%
4 Communication Services 11.47%
5 Financials 11.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PLRX icon
301
Pliant Therapeutics
PLRX
$71.8M
– –
-490,000
Closed -$14.3M
RCKT icon
302
Rocket Pharmaceuticals
RCKT
$385M
– –
-350,000
Closed -$15.5M
SMRT icon
303
SmartRent
SMRT
$274M
– –
-400,000
Closed -$4.92M
TBPH icon
304
Theravance Biopharma
TBPH
$883M
– –
-96,000
Closed -$1.39M
TGTX icon
305
TG Therapeutics
TGTX
$8.31B
– –
-500,000
Closed -$19.4M
IMGN
306
DELISTED
Immunogen Inc
IMGN
– –
-750,000
Closed -$4.94M
EMBKW
307
DELISTED
Embark Technology, Inc. Warrants
EMBKW
– –
-92,675
Closed -$154K
FNCH
308
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
– –
-6,178
Closed -$2.61M
PSPC.U
309
DELISTED
Post Holdings Partnering Corporation Units, each consisting of one share of Series A common stock, and one-third of one redeemable warrant
PSPC.U
– –
-800,000
Closed -$8.31M
ALBO
310
DELISTED
Albireo Pharma Inc
ALBO
– –
-250,000
Closed -$8.79M
CPARU
311
DELISTED
Catalyst Partners Acquisition Corp. Unit
CPARU
– –
-753,900
Closed -$7.57M
SHQAU
312
DELISTED
Shelter Acquisition Corporation I Units
SHQAU
– –
-1,650,000
Closed -$16.5M
TPTX
313
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
– –
-465,000
Closed -$36.3M
SPAQ.WS
314
DELISTED
Spartan Acquisition Corp. III Warrants, exercisable for one share of Class A Common Stock
SPAQ.WS
– –
-15,013
Closed -$18K
CVA
315
DELISTED
Covanta Holding Corporation
CVA
– –
-115,000
Closed -$2.02M
MDLA
316
DELISTED
Medallia, Inc.
MDLA
– –
-240,000
Closed -$8.1M
SRNGW
317
DELISTED
Soaring Eagle Acquisition Corp. Warrant
SRNGW
– –
-100,000
Closed -$330K
SRNG
318
DELISTED
Soaring Eagle Acquisition Corp. Class A Ordinary Share
SRNG
– –
-500,000
Closed -$4.98M
PFPT
319
DELISTED
Proofpoint, Inc.
PFPT
– –
-304,500
Closed -$52.9M
CEREW
320
DELISTED
Cerevel Therapeutics Holdings, Inc. Warrant
CEREW
– –
-134,175
Closed -$1.91M
MXIM
321
DELISTED
Maxim Integrated Products
MXIM
– –
-4,515,000
Closed -$476M
TLND
322
DELISTED
Talend S.A. American Depositary Shares
TLND
– –
-380,000
Closed -$24.9M
ALXN
323
DELISTED
Alexion Pharmaceuticals
ALXN
– –
-7,707,500
Closed -$1.42B
WORK
324
DELISTED
Slack Technologies, Inc.
WORK
– –
-10,437,300
Closed -$462M
INBX
325
DELISTED
Inhibrx, Inc. Common Stock
INBX
– –
-569,328
Closed -$15.7M
9 10 11 12
13

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Thomas Steyer's Q3 2021 Portfolio in Review

As of Q3 2021, Thomas Steyer held 335 positions worth $21.4B, down 13% from $24.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Thomas Steyer withdrew a net $3.45B in Q3 2021, closing 34 positions and reducing 44 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $1.42B position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 30% a quarter earlier, followed by Technology and Industrials.

Against the trend, Thomas Steyer opened a new position in Macquarie Infrastructure Holdings, LLC worth $177M.

  • Thomas Steyer's largest Q3 2021 buy was Macquarie Infrastructure Holdings, LLC: 4,361,050 shares worth $177M.
  • Thomas Steyer added most to Aramark in Q3 2021, an estimated $209M increase.
  • Thomas Steyer's biggest Q3 2021 reduction was Willis Towers Watson, cutting an estimated $468M.
  • Thomas Steyer fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $1.42B.
  • Thomas Steyer's ten largest holdings make up 34% of its $21.4B portfolio in Q3 2021.
  • Thomas Steyer opened 40 new positions and closed 34 in Q3 2021.
  • Thomas Steyer's portfolio value fell 13% quarter-over-quarter to $21.4B.

Based on Farallon Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.